Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants

Objective To systematically review and qualitatively evaluate epidemiological evidence on associations between Parkinson’s disease (PD) and cancer via meta-analysis.Data sources MEDLINE via PubMed, Web of Science and EMBASE, until March 2021.Study selection Included were publications that (1) were o...

Full description

Bibliographic Details
Main Authors: Xiang Gao, Xinyuan Zhang, David Guarin, Niyaz Mohammadzadehhonarvar, Xiqun Chen
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/7/e046329.full
id doaj-7444e08cac65491d9e96adc937a11d83
record_format Article
spelling doaj-7444e08cac65491d9e96adc937a11d832021-10-06T08:00:05ZengBMJ Publishing GroupBMJ Open2044-60552021-07-0111710.1136/bmjopen-2020-046329Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participantsXiang Gao0Xinyuan Zhang1David Guarin2Niyaz Mohammadzadehhonarvar3Xiqun Chen4Nutritional Science, The Pennsylvania State University, University Park, Pennsylvania, USANutritional Science, The Pennsylvania State University, University Park, Pennsylvania, USANeurology, Massachusetts General Hospital, Boston, Massachusetts, USANeurology, Massachusetts General Hospital, Boston, Massachusetts, USANeurology, Massachusetts General Hospital, Boston, Massachusetts, USAObjective To systematically review and qualitatively evaluate epidemiological evidence on associations between Parkinson’s disease (PD) and cancer via meta-analysis.Data sources MEDLINE via PubMed, Web of Science and EMBASE, until March 2021.Study selection Included were publications that (1) were original epidemiological studies on PD and cancer; (2) reported risk estimates; (3) were in English. Exclusion criteria included: (1) review/comments; (2) biological studies; (3) case report/autopsy studies; (4) irrelevant exposure/outcome; (5) treated cases; (6) no measure of risk estimates; (7) no confidence intervals/exact p values and (8) duplicates.Data extraction and synthesis PRISMA and MOOSE guidelines were followed in data extraction. Two-step screening was performed by two authors blinded to each other. A random-effects model was used to calculate pooled relative risk (RR).Main outcomes and measures We included publications that assessed the risk of PD in individuals with vs without cancer and the risk of cancer in individuals with vs without PD.Results A total of 63 studies and 17 994 584 participants were included. Meta-analysis generated a pooled RR of 0.82 (n=33; 95% CI 0.76 to 0.88; p<0.001) for association between PD and total cancer, 0.76 (n=21; 95% CI 0.67 to 0.85; p<0.001) for PD and smoking-related cancer and 0.92 (n=19; 95% CI 0.84 to 0.99; p=0.03) for non-smoking-related cancer. PD was associated with an increased risk of melanoma (n=29; pooled RR=1.75; 95% CI 1.43 to 2.14; p<0.001) but not for other skin cancers (n=17; pooled RR=0.90; 95% CI 0.60 to 1.34; p=0.60).Conclusions PD and total cancer were inversely associated. This inverse association persisted for both smoking-related and non-smoking-related cancers. PD was positively associated with melanoma. These results provide evidence for further investigations for possible mechanistic associations between PD and cancer.Prospero registration number CRD42020162103.https://bmjopen.bmj.com/content/11/7/e046329.full
collection DOAJ
language English
format Article
sources DOAJ
author Xiang Gao
Xinyuan Zhang
David Guarin
Niyaz Mohammadzadehhonarvar
Xiqun Chen
spellingShingle Xiang Gao
Xinyuan Zhang
David Guarin
Niyaz Mohammadzadehhonarvar
Xiqun Chen
Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
BMJ Open
author_facet Xiang Gao
Xinyuan Zhang
David Guarin
Niyaz Mohammadzadehhonarvar
Xiqun Chen
author_sort Xiang Gao
title Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title_short Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title_full Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title_fullStr Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title_full_unstemmed Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title_sort parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
publisher BMJ Publishing Group
series BMJ Open
issn 2044-6055
publishDate 2021-07-01
description Objective To systematically review and qualitatively evaluate epidemiological evidence on associations between Parkinson’s disease (PD) and cancer via meta-analysis.Data sources MEDLINE via PubMed, Web of Science and EMBASE, until March 2021.Study selection Included were publications that (1) were original epidemiological studies on PD and cancer; (2) reported risk estimates; (3) were in English. Exclusion criteria included: (1) review/comments; (2) biological studies; (3) case report/autopsy studies; (4) irrelevant exposure/outcome; (5) treated cases; (6) no measure of risk estimates; (7) no confidence intervals/exact p values and (8) duplicates.Data extraction and synthesis PRISMA and MOOSE guidelines were followed in data extraction. Two-step screening was performed by two authors blinded to each other. A random-effects model was used to calculate pooled relative risk (RR).Main outcomes and measures We included publications that assessed the risk of PD in individuals with vs without cancer and the risk of cancer in individuals with vs without PD.Results A total of 63 studies and 17 994 584 participants were included. Meta-analysis generated a pooled RR of 0.82 (n=33; 95% CI 0.76 to 0.88; p<0.001) for association between PD and total cancer, 0.76 (n=21; 95% CI 0.67 to 0.85; p<0.001) for PD and smoking-related cancer and 0.92 (n=19; 95% CI 0.84 to 0.99; p=0.03) for non-smoking-related cancer. PD was associated with an increased risk of melanoma (n=29; pooled RR=1.75; 95% CI 1.43 to 2.14; p<0.001) but not for other skin cancers (n=17; pooled RR=0.90; 95% CI 0.60 to 1.34; p=0.60).Conclusions PD and total cancer were inversely associated. This inverse association persisted for both smoking-related and non-smoking-related cancers. PD was positively associated with melanoma. These results provide evidence for further investigations for possible mechanistic associations between PD and cancer.Prospero registration number CRD42020162103.
url https://bmjopen.bmj.com/content/11/7/e046329.full
work_keys_str_mv AT xianggao parkinsonsdiseaseandcancerasystematicreviewandmetaanalysisofover17millionparticipants
AT xinyuanzhang parkinsonsdiseaseandcancerasystematicreviewandmetaanalysisofover17millionparticipants
AT davidguarin parkinsonsdiseaseandcancerasystematicreviewandmetaanalysisofover17millionparticipants
AT niyazmohammadzadehhonarvar parkinsonsdiseaseandcancerasystematicreviewandmetaanalysisofover17millionparticipants
AT xiqunchen parkinsonsdiseaseandcancerasystematicreviewandmetaanalysisofover17millionparticipants
_version_ 1716841160809381888